Condition (MeSH)
Parasitemia
ClinicalTrials.gov lists 20 trials for Parasitemia or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 12.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 20 trials are tagged with Parasitemia itself; the rest are tagged with a narrower condition beneath it.
When did Parasitemia trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 2 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 2 |
| 2014 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Parasitemia trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 9 |
| Phase 2 | 3 |
| Not applicable | 1 |
| Observational | 7 |
How many Parasitemia trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 18 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Parasitemia trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 12 |
| Ministry of Health, Bhutan | 1 |
| Novartis Pharmaceuticals | 1 |
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| P. falciparum IBSM infection | 2 |
| VRC-MALMAB0100-00-AB | 1 |
| Ibuprofen 2% | 1 |
| MMV367 1500mg | 1 |
| Pyrimethamine/sulfadoxine | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Parasitemia trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Neurologic deficits at discharge | 19 | 1 |
| Death | 13 | 1 |
| Creatinine increase | 3 | 1 |
| Alanine aminotransferase increased | 2 | 1 |
| Any bleeding | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Parasitemia? (261)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial. | JAMA network open | 2025 | Yes |
| Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults. | The Journal of infectious diseases | 2025 | Yes |
| Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite. | The New England journal of medicine | 2024 | Yes |
| The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria. | The Journal of infectious diseases | 2022 | Yes |
| Safety and feasibility of apheresis to harvest and concentrate parasites from subjects with induced blood stage Plasmodium vivax infection. | Malaria journal | 2021 | Yes |
Showing 5 of 261 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.